Adding Mitomycin to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive -bladder cancer: A randomised phase 3 trial: The BCG+MM Study (ANZUP1301)

Saved in:
Bibliographic Details
Published in:European urology 2023-02, Vol.83, p.S746-S747
Main Authors: Hayne, D., Stockler, M., Martin, A.J., Mccombie, S., Zebic, D., Krieger, L., Anderson, P., Bastick, P., Beardsley, E., Blatt, A., Frydenberg, M., Green, W., Grummet, J., Hawks, C., Ischia, J., Mitterdorfer, A., Patel, M., Roberts, M., Sengupta, S., Srivastav, R., Winter, M., Redfern, A.D., Davis, I.D.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0302-2838
DOI:10.1016/S0302-2838(23)00567-5